Literature DB >> 22868276

Adverse cardiac events during catecholamine therapy: a role for hydrocortisone?

A Salvadori, P Pasquier, A Jarrassier, J Renner, S Merat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22868276     DOI： 10.1007/s00134-012-2663-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the Corticus study.

Authors:  R Moreno; C L Sprung; D Annane; S Chevret; J Briegel; D Keh; M Singer; Y G Weiss; D Payen; B H Cuthbertson; J-L Vincent
Journal:  Intensive Care Med       Date:  2011-08-17       Impact factor: 17.440

2.  Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study.

Authors:  Christian A Schmittinger; Christian Torgersen; Günter Luckner; Daniel C H Schröder; Ingo Lorenz; Martin W Dünser
Journal:  Intensive Care Med       Date:  2012-04-12       Impact factor: 17.440

Review 3.  Safety and efficacy of corticosteroids for the treatment of septic shock: A systematic review and meta-analysis.

Authors:  Wendy I Sligl; Danny A Milner; Sugantha Sundar; Wendy Mphatswe; Sumit R Majumdar
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

Review 4.  Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review.

Authors:  Djillali Annane; Eric Bellissant; Pierre-Edouard Bollaert; Josef Briegel; Marco Confalonieri; Raffaele De Gaudio; Didier Keh; Yizhak Kupfer; Michael Oppert; G Umberto Meduri
Journal:  JAMA       Date:  2009-06-10       Impact factor: 56.272

5.  Hydrocortisone therapy for patients with septic shock.

Authors:  Charles L Sprung; Djillali Annane; Didier Keh; Rui Moreno; Mervyn Singer; Klaus Freivogel; Yoram G Weiss; Julie Benbenishty; Armin Kalenka; Helmuth Forst; Pierre-Francois Laterre; Konrad Reinhart; Brian H Cuthbertson; Didier Payen; Josef Briegel
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.